You noticed it in an overhead photo — the crown, the temples, whatever the camera caught. If a provider has discussed oral minoxidil with you, the hardest part of the first two weeks is resisting the urge to grade it. Here is what those weeks actually involve, and why judging early tells you almost nothing.
Why the hair cycle makes the first two weeks a poor judge
Hair grows in a cycle: a long growth phase (anagen), a brief transition (catagen), and a resting phase (telogen) before the strand sheds and a new one begins [1]. In androgenetic alopecia — the common pattern behind a thinning crown or receding temples — hormonally sensitive follicles progressively shorten their growth phase and shrink, a process called miniaturization [2]. That process took years to become visible in your photos. It will not visibly change in fourteen days.
Minoxidil is thought to work partly by shifting follicles into and prolonging the growth phase and by acting on the follicle's blood supply as a vasodilator; the precise mechanism is still not fully mapped [3]. What matters practically is the lag: because you are working with a slow biological cycle, meaningful visual assessment is a matter of months, not weeks. Most clinical evaluations of minoxidil measure change at roughly 16 to 48 weeks, not at day 14 [4].
Source: [1] Hair Follicle Biology and the Hair Growth Cycle (StatPearls, NIH Bookshelf), [4] A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men
The settling-in period: what "normal" can look like early
Two early experiences catch people off guard.
A temporary increase in shedding. Some people notice more shed hairs in the first weeks. The working explanation is that resting-phase hairs are pushed out as follicles are nudged back into a growth phase — old strands making room for new ones. It can be unsettling, but it is a recognized early pattern rather than a sign the medication is failing [3]. This is exactly the moment a lot of people quit — and quitting on week two means you never learn what month four would have shown.
Systemic effects, because this is a pill. Minoxidil was originally developed as an oral blood-pressure medication, and even at the low doses used off-label for hair, it is absorbed body-wide [5]. That is why the relevant early side-effect signals are cardiovascular and fluid-related: lightheadedness, a faster resting heart rate, ankle or facial swelling from fluid retention, and unwanted body-hair growth [5][6]. A published review of low-dose oral minoxidil for hair loss found that increased body hair was the most commonly reported side effect and that serious cardiovascular events were uncommon in the reported populations [6]. "Uncommon" is not "impossible," which is precisely why an independent provider reviews your history before prescribing and sets check-in points afterward.
This article is educational and is not medical advice. Whether any medication is appropriate for you — oral, topical, or neither — is a decision only a licensed provider can make after reviewing your history.
Adherence traps that quietly sink the first month
The most common reason a reasonable protocol doesn't get a fair trial is not side effects — it's inconsistency. A few traps to name out loud:
- The two-week verdict. Deciding "it's not working" before the hair cycle could possibly show anything. See the timeline above.
- The shedding scare. Interpreting early shedding as failure and stopping. If shedding is heavy, prolonged, or worrying you, that is a message-your-provider moment, not a quit-on-your-own moment.
- Skipping doses around a busy week. For a dad juggling work and kids, or someone constantly on work trips, a missed-dose pattern is easy to fall into. Minoxidil's effect depends on continued use; benefits are understood to fade after stopping [3][4]. Anchoring the pill to an existing daily habit helps more than willpower.
- Stacking changes. Starting several new things at once makes it impossible to tell what caused what — including any side effect.
The checkpoints a provider actually reviews
Before starting, and at follow-ups, an independent provider is generally looking at a specific set of things rather than your mirror on day 14:
Baseline suitability. Cardiovascular history, blood pressure, current medications, and conditions that make fluid retention risky are all part of deciding whether oral minoxidil is even a candidate for you [5][6]. This is also where the oral-versus-topical question gets sorted — a conversation, not a checkbox.
Early tolerance. In the first weeks the review is about *safety signals*, not regrowth: resting heart rate, any swelling, blood pressure changes, and how you feel day to day [5][6].
Objective tracking over months. Because eyeballing your own crown is unreliable, providers lean on standardized photos taken in consistent lighting and, sometimes, global photographic assessment scales — the same approach used in clinical studies to measure change at 16-plus weeks [4]. This is the real answer to "is it working": a fixed-position photo now, compared to one months from now, under the same light that first alarmed you.
Family history and pattern. Strong early male-pattern loss in the family raises the stakes on *keeping* what you have. The framing shifts from chasing regrowth to slowing progression, which changes what a realistic result even looks like [2].
Source: [4] A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men, [6] Low-Dose Oral Minoxidil for Hair Loss: A Systematic Review (Journal of the American Academy of Dermatology / PubMed)
A realistic mental model for the first two weeks
Treat the first two weeks as the *adjustment* window, not the *judgment* window. Your job is narrow: take it consistently, log how you feel, take a baseline photo in steady overhead light, and report anything cardiovascular or swelling-related to your provider. Save the verdict for the checkpoints your provider sets — typically measured in months, aligned to the hair cycle rather than to your patience [1][4].
Avoid unvetted overseas or gray-market sources. The value of a physician-directed route is not just the molecule in the bottle — it's the baseline review, the defined check-ins, and a licensed pharmacy in the chain of custody.
Where Velri fits
Velri is a technology and coordination company — it does not provide medical care. What Velri coordinates is the boring-but-important scaffolding: helping arrange any labs or intake an independent provider wants, connecting you to a licensed provider group for a real evaluation of whether a hair-loss medication is appropriate for you, and — only if that independent provider prescribes — coordinating fulfillment through an independent licensed pharmacy. A prescription is never guaranteed; that decision belongs entirely to the provider.
Everything is handled from home, on your schedule, with a subscription you can cancel. If a compounded formulation is ever involved: compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
This content is educational and is not medical advice, diagnosis, or a recommendation to take any specific medication. Talk with a licensed provider about your individual situation.
